| Literature DB >> 32558395 |
Marianna Vachalcova1,2, Gabriel Valočik1,2, Marián Kurečko1,2, Julia Grapsa3, Viktória Ali Taha4, Peter Michalek5,6, Monika Jankajová1,2, František Sabol1,2, Lucia Kubikova1,2, Marek Orban6,7, Tomas Uher8,9, Allan Böhm7,10,8.
Abstract
AIMS: The aim of this pilot study was to compare selected three-dimensional speckle tracking echocardiography (3D STE) parameters in patients with ischaemic and non-ischaemic aetiology of heart failure (HF) and to identify indices that can differentiate the two pathologies. METHODS ANDEntities:
Keywords: 3D echocardiography; Apical rotation; Coronary artery disease; Heart failure aetiology; Non-ischaemic cardiomyopathy; Speckle tracking echocardiography
Mesh:
Year: 2020 PMID: 32558395 PMCID: PMC7524069 DOI: 10.1002/ehf2.12766
Source DB: PubMed Journal: ESC Heart Fail ISSN: 2055-5822
Baseline characteristics
| ICM | NICM |
| |
|---|---|---|---|
| Age (years) | 62.55 ± 9.04 | 64.00 ± 10.95 | 0.65 |
| Sex (male) (%) | 19 (95) | 15 (75) | 0.18 |
| SBP (mmHg) | 135.61 ± 21.82 | 124.75 ± 15.60 | 0.09 |
| DBP (mmHg) | 81.28 ± 13.72 | 77.50 ± 15.94 | 0.44 |
| Height (cm) | 172.00 ± 6.15 | 170.20 ± 7.95 | 0.43 |
| Weight (kg) | 83.00 ± 11.94 | 80.75 ± 12.81 | 0.57 |
| Body mass index (kg/m2) | 28.29 ± 3.79 | 28.00 ± 3.55 | 0.80 |
| Heart rate (bpm) | 74.90 ± 14.49 | 73.90 ± 12.89 | 0.89 |
| DM. | 9 (45) | 6 (30) | 0.51 |
| Hypercholesterolemia (%) | 12 (60) | 6 (30) | 0.11 |
| Creatinine (umol/L) | 115.21 ± 20.79 | 116.50 ± 30.91 | 0.88 |
| AFib (%) | 7 (35) | 6 (30) |
|
| NYHA class II (%) | 3 (15) | 2 (10) |
|
| NYHA class III (%) | 16 (80) | 18 (90) | 0.66 |
| Beta blockers (%) | 18 (90) | 17 (85) |
|
| ACEi/ARB (%) | 18 (90) | 13 (65) | 0.13 |
| Aldosterone antagonist (%) | 14 (70) | 9 (45) | 0.20 |
| Akinesia in ALAW (%) | 5 (26) | 3 (16) | 0.46 |
| Myocardial infarction (%) | 3 (16) | 0 | Not applicable |
| PCI/CABG (%) | 7 (35) | 0 | Not applicable |
ACEi/ARB, angiotensin converting enzyme inhibitor/angiotensin receptor blocker; Afib, atrial fibrillation; ALAW, anterolateral and apical wall; CABG, coronary artery bypass grafting; DBP, diastolic blood pressure; DM, diabetes mellitus; ICM, ischaemic cardiomyopathy; NICM, non‐ischaemic cardiomyopathy; NT‐proBNP, N terminal pro b‐type natriuretic peptide; NYHA, New York Heart Association; PCI, percutaneous coronary intervention; SBP, systolic blood pressure.
Data as mean ± standard deviation or n (%).
Volumetric data and functional parameters
| ICM (20) | NICM (20) |
| |
|---|---|---|---|
| LVAR, ° | 4.91 ± 3.48 | 2.29 ± 2.36 |
|
| LVBR, ° | −2.21 ± 2.39 | −2.80 ± 1.71 | 0.14 |
| Twist, ° | 5.25 ± 4.51 | 3.48 ± 3.31 | 0.15 |
| Torsion, °/cm | 0.65 ± 0.59 | 0.43 ± 0.39 | 0.17 |
| GLS, % | −7.99 ± 4.49 | −8.40 ± 2.93 | 0.73 |
| EF, % | 29.03 ± 11.26 | 27.25 ± 7.52 | 0.56 |
| EDV, mL | 168.08 ± 52.83 | 170.83 ± 62.45 | 0.88 |
| ESV, mL | 120.45 ± 47.61 | 126.53 ± 55.29 | 0.84 |
| LAV, mL | 76.77 ± 45.88 | 67.35 ± 29.80 | 0.61 |
| LAVI, mL/m2 | 40.09 ± 25.52 | 37.32 ± 15.01 | 0.99 |
| SDI, % | 7.99 ± 4.19 | 9.83 ± 5.39 | 0.37 |
| EDT, ms | 167.06 ± 71.32 | 215.15 ± 114.84 | 0.13 |
| E/A | 1.61 ± 1.47 | 1.27 ± 1.17 | 0.28 |
| E/Em | 14.94 ± 9.16 | 12.84 ± 5.02 | 0.70 |
EDV, end‐diastolic volume; EDT, E wave deceleration time; EF, ejection fraction; Em, tissue Doppler early diastolic myocardial velocity of the basal septum; ESV, endsystolic volume; GLS, global longitudinal strain; ICM, ischaemic cardiomyopathy; LAV, left atrial volume; LV AR, left ventricular apical rotation; LV BR, left ventricular basal rotation; NICM, non‐ischaemic cardiomyopathy; SDI, systolic dyssynchrony index.
Data as mean ± standard deviation.
Figure 1Box and whisker plot. ICH, ischaemic cardiomyopathy; NICH, non‐ischaemic cardiomyopathy.
Figure 2Three‐dimensional echocardiographic assessment of left ventricular volumetric parameters in ischaemic cardiomyopathy.
Figure 3Three‐dimensional echocardiographic assessment of left ventricular rotational parameters in non‐ischaemic cardiomyopathy. EDV, end diastolic volume; ESV, end systolic volume; SV, stroke volume; EF, ejection fraction; GLS, global longitudinal strain.
Multivariate analysis
| Odds ratio | (95% confidence interval) |
| |
|---|---|---|---|
| LVAR, ° | 1.54 | (1.06–2.24) | 0.025 |
| MI | 0.74 | (0.28–55.54) | 0.75 |
| Akinesia in ALAW | 3.96 | (0.11–4.94) | 0.30 |
ALAW, anterolateral and apical wall; LV AR, left ventricular apical rotation; MI, myocardial infarction.
Figure 4Receiver operating characteristic curve for the apical rotation.
Intra‐observer and inter‐observer reproducibility
| ICC for intra‐observer reproducibility | ICC for inter‐observer reproducibility | |
|---|---|---|
| LVAR, ° | 0.95 | 0.98 |
| LVBR, ° | 0.99 | 0.99 |
| Twist, ° | 0.96 | 0.93 |
| Torsion, °/cm | 0.94 | 0.92 |
| GLS, % | 0.95 | 0.95 |
GLS, global longitudinal strain; ICC, intra‐class correlation coefficient; LV AR, left ventricular apical rotation; LV BR, left ventricular basal rotation.